Carna Biosciences, Inc.
カルナバイオサイエンス株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4572
FY2025 · 2025-12-31
| Gross margin | 67.0% |
| Operating margin | -358.3% |
| Net margin | -375.0% |
| Return on equity | -941.4% |
| Return on assets | -176.6% |
| Revenue growth (YoY) | -9.0% |
| EPS (basic) | ¥-113.62 |
| EPS growth (YoY) | — |
| Current ratio | 6.99x |
| Equity ratio | 18.8% |
| Book value / share | ¥16.16 |
| Free cash flow | -2,169 M |